Future Medicine

Lee, I. et al. “Autologous cell immunotherapy (IGV-001) with IGF-1R antisense oligonucleotide in newly diagnosed glioblastoma patients.” Future Medicine, Dec. 2023. DOI 10.2217/fon-2023-0702